PUBLIC STUDY US B2B 2025
Investing in healthcare
Following tariff-related uncertainty, the healthcare private equity investment landscape is expected to be shaped by a mix of optimism and caution. Stax and Potloc surveyed 200 healthcare PE investors to decode deal flow in 2025.
Healthcare investors are navigating tariff uncertainty with optimism.
Even in the face of tariff uncertainty and macroeconomic headwinds, most investors expect steady or increased deal activity. Attractive assets, long hold periods, and LP pressure are driving deployment, while diligence priorities are shifting toward pricing sensitivity, supply chain, and AI in hospital operations.
To gather these insights and support their clients, Stax chose Potloc’s survey platform to source these findings from 200 healthcare-focused PE investors in the US.

Darren Buskirk
Managing Director, Chicago at Stax

Jordan Adams
Senior Manager, Boston at Stax

Nam Nguyen
Managing Director, North America at Potloc
Survey details.
-
200
Healthcare-focused PE investors surveyed
-
5
firm tiers broken down by $AUM
-
14
data quality controls employed
-
11
days of fieldwork
Key trends.
Optimism expected to drive capital deployment.
Confidence in healthcare deal flow and investment activity remains positive. On average, investors anticipate deploying about 6% more healthcare capital in 2025 compared to 2024.
Tariff uncertainty reshaping due diligence considerations.
AI expected to play a role.
A majority of investors expect AI to play a significant or very significant role in 2025 deal flow, with hospital operations software emerging as the leading investment area they see being significantly shaped by AI.
Our team.
Nam Nguyen
MANAGING DIRECTOR, NORTH AMERICA
nam.nguyen@potloc.com
Kickstart your next thought leadership survey.
With unmatched sample quality, time-saving analysis tools, and dedicated research experts at your disposal, Potloc is the go-to survey partner for PE & consulting firms.